Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02118064 | Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma(CC6) | completed | Phase 2 | 161 | Cancer Advances Inc.INDUSTRY | 0 | Apr 21, 2014 | clinicaltrials |
| NCT00109226 | A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Genentech, Inc.INDUSTRY | 0 | Apr 8, 2014 | clinicaltrials |
| NCT01941966 | A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. | completed | Phase 2 | 51 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Mar 28, 2014 | clinicaltrials |
| NCT00494221 | A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX | completed | Phase 1 / Phase 2 | 172 | AstraZenecaINDUSTRY | 1 | Mar 27, 2014 | clinicaltrials |
| NCT01320267 | Single Port Laparoscopic Colectomy(SILS) | withdrawn | Phase 1 / Phase 2 | 0 | University of British ColumbiaOTHER | 0 | Mar 17, 2014 | clinicaltrials |
| NCT00003786 | Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer | withdrawn | Phase 2 | 0 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00003950 | Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer | completed | Phase 2 | 16 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT01434147 | Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy | completed | Phase 2 | 25 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Mar 7, 2014 | clinicaltrials |
| NCT01426490 | The Effects of Vitamin B-6 Status on Homocysteine, Oxidative Stress, One-carbon Metabolism and Methylation: Cross-section, Case-control, Intervention and Follow-up Studies in Colorectal Cancer | unknown | Phase 2 / Phase 3 | 300 | Taichung Veterans General HospitalOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00630786 | Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study | completed | Phase 1 / Phase 2 | 53 | AmgenINDUSTRY | 0 | Feb 6, 2014 | clinicaltrials |
| NCT00606398 | Combined Resection of Colorectal Metastases(CRC) | completed | Phase 2 | 56 | University Health Network, TorontoOTHER | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00795301 | A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab | unknown | Phase 2 | 74 | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00819754 | A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer(IXO+A) | terminated | Phase 1 / Phase 2 | 23 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00967655 | Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer | unknown | Phase 2 | 54 | Loma Linda Oncology Medical Group, Inc.OTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT01067053 | Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.(BECOX) | unknown | Phase 2 | 69 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00027833 | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | — | Herbert Irving Comprehensive Cancer CenterOTHER | 2 | Jan 6, 2014 | clinicaltrials |
| NCT00297141 | Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma | completed | Phase 2 | 60 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Dec 31, 2013 | clinicaltrials |
| NCT02022852 | Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer | unknown | Phase 2 | 80 | Harbin Medical UniversityOTHER | 1 | Dec 30, 2013 | clinicaltrials |
| NCT00408551 | Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver | unknown | Phase 2 | 20 | Goshen Health SystemOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00975897 | Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer | completed | Phase 2 / Phase 3 | 3,240 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00031616 | NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer | unknown | Phase 1 / Phase 2 | — | NewBioticsINDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00111761 | Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 43 | AmgenINDUSTRY | 0 | Dec 12, 2013 | clinicaltrials |
| NCT00852228 | Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy(OPTILIV) | unknown | Phase 2 | 60 | Association pour la Recherche sur le Temps Biologique et la ChronothérapieOTHER | 4 | Dec 12, 2013 | clinicaltrials |
| NCT00005874 | Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas | completed | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00005877 | Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer | unknown | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00025441 | Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors | completed | Phase 2 | — | Societe Internationale d'Oncologie PediatriqueOTHER | 3 | Dec 4, 2013 | clinicaltrials |
| NCT01529164 | Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer | unknown | Phase 2 | 51 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 27, 2013 | clinicaltrials |
| NCT00215982 | Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal Cancer | completed | Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Nov 25, 2013 | clinicaltrials |
| NCT00986518 | T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study(STARTREK) | completed | Phase 1 / Phase 2 | 5 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01344902 | An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon | terminated | Phase 1 / Phase 2 | 13 | PhotocureINDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
| NCT00262808 | GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | completed | Phase 2 | 50 | University of RochesterOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00909987 | Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum | completed | Phase 2 | 46 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00007826 | Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | — | OnyvaxINDUSTRY | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00625625 | Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | unknown | Phase 2 | 225 | Saint John's Cancer InstituteOTHER | 0 | Sep 17, 2013 | clinicaltrials |
| NCT01110785 | Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 46 | Leiden University Medical CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00475293 | Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC | completed | Phase 2 | 85 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Sep 13, 2013 | clinicaltrials |
| NCT00022477 | BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer | completed | Phase 2 | 24 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00026299 | Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | completed | Phase 1 / Phase 2 | 14 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01075399 | Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors(HX4-200) | completed | Phase 2 | 50 | Siemens Molecular ImagingINDUSTRY | 0 | Aug 30, 2013 | clinicaltrials |
| NCT00669812 | High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma | unknown | Phase 2 | 60 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01086618 | Chemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | completed | Phase 2 / Phase 3 | 500 | University College London HospitalsOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01586117 | A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00974389 | S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery | unknown | Phase 2 | 40 | Osaka Medical CollegeOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01097265 | Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery | unknown | Phase 2 / Phase 3 | 1,500 | Jeroen Bosch ZiekenhuisOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01190462 | Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | unknown | Phase 2 | 51 | Leiden University Medical CenterOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00033306 | BMS-247550 in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 2 | University of Alabama at BirminghamOTHER | 1 | Aug 5, 2013 | clinicaltrials |
| NCT00026468 | Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis | withdrawn | Phase 2 / Phase 3 | 0 | University of UtahOTHER | 0 | Jul 24, 2013 | clinicaltrials |
| NCT00026234 | Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver | completed | Phase 2 | 75 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Apr 21, 2014source: clinicaltrials